| NTRA |
Natera, Inc. |
0 |
3.57% |
|
|
|
|
|
N/A |
0.00% |
34.66% |
16.97% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
2.94% |
|
|
|
|
|
N/A |
0.00% |
24.54% |
19.21% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
88.89% |
95.34% |
|---|
| INCY |
Incyte Corporation |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
31.53% |
32.12% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
2.88% |
|
|
|
|
|
N/A |
0.00% |
24.23% |
9.87% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
2.69% |
|
|
|
|
|
N/A |
0.00% |
88.39% |
43.42% |
|---|
| INSM |
Insmed Incorporated |
0 |
2.60% |
|
|
|
|
|
N/A |
0.00% |
42.54% |
16.40% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
2.55% |
|
|
|
|
|
N/A |
0.00% |
25.64% |
13.66% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
2.45% |
|
|
|
|
|
N/A |
0.00% |
45.90% |
16.92% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
2.43% |
|
|
|
|
|
N/A |
0.00% |
34.56% |
17.63% |
|---|
| ABBV |
AbbVie Inc. |
0 |
2.34% |
|
|
|
|
|
N/A |
0.00% |
19.59% |
0.32% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
0 |
2.17% |
|
|
|
|
|
N/A |
0.00% |
47.10% |
11.46% |
|---|
| AMGN |
Amgen Inc. |
0 |
2.12% |
|
|
|
|
|
N/A |
0.00% |
20.35% |
2.65% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
2.04% |
|
|
|
|
|
N/A |
0.00% |
31.44% |
14.49% |
|---|
| BIIB |
Biogen Inc. |
0 |
2.03% |
|
|
|
|
|
N/A |
0.00% |
28.48% |
16.29% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
0 |
1.87% |
|
|
|
|
|
N/A |
0.00% |
73.50% |
19.91% |
|---|
| TGTX |
TG Therapeutics, Inc. |
0 |
1.83% |
|
|
|
|
|
N/A |
0.00% |
50.57% |
19.94% |
|---|
| BPMC |
BLUEPRINT MEDICINES CORP |
|
1.74% |
|
|
|
|
|
|
|
|
|
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
1.66% |
|
|
|
|
|
N/A |
0.00% |
32.11% |
31.90% |
|---|
| CYTK |
Cytokinetics, Incorporated |
0 |
1.64% |
|
|
|
|
|
N/A |
0.00% |
65.81% |
33.05% |
|---|
| MRNA |
Moderna, Inc. |
0 |
1.62% |
|
|
|
|
|
N/A |
0.00% |
57.35% |
8.62% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
1.48% |
|
|
|
|
|
N/A |
0.00% |
56.52% |
30.13% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
1.39% |
|
|
|
|
|
N/A |
0.00% |
40.62% |
12.80% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
1.25% |
|
|
|
|
|
N/A |
0.00% |
26.81% |
21.28% |
|---|
| ROIV |
Roivant Sciences Ltd. |
0 |
1.24% |
|
|
|
|
|
N/A |
0.00% |
38.83% |
65.35% |
|---|
| ALKS |
Alkermes plc |
0 |
1.22% |
|
|
|
|
|
N/A |
0.00% |
61.34% |
45.41% |
|---|
| KRYS |
Krystal Biotech, Inc. |
0 |
1.20% |
|
|
|
|
|
N/A |
0.00% |
34.82% |
16.27% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
1.18% |
|
|
|
|
|
N/A |
0.00% |
57.46% |
55.59% |
|---|
| RVMD |
Revolution Medicines, Inc. |
0 |
1.17% |
|
|
|
|
|
N/A |
0.00% |
41.82% |
26.72% |
|---|
| ADMA |
ADMA Biologics, Inc. |
0 |
1.16% |
|
|
|
|
|
N/A |
0.00% |
44.87% |
3.71% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
0 |
1.07% |
|
|
|
|
|
N/A |
0.00% |
43.95% |
1.77% |
|---|
| BBIO |
BridgeBio Pharma, Inc. |
0 |
1.05% |
|
|
|
|
|
N/A |
0.00% |
42.15% |
1.18% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
1.05% |
|
|
|
|
|
N/A |
0.00% |
75.80% |
25.16% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
1.04% |
|
|
|
|
|
N/A |
0.00% |
78.94% |
39.80% |
|---|
| PCVX |
Vaxcyte, Inc. |
0 |
0.90% |
|
|
|
|
|
N/A |
0.00% |
52.03% |
31.32% |
|---|
| BHVN |
Biohaven Pharmaceutical Holding Company ... |
0 |
0.89% |
|
|
|
|
|
N/A |
0.00% |
106.90% |
49.25% |
|---|
| GERN |
Geron Corporation |
0 |
0.85% |
|
|
|
|
|
N/A |
0.00% |
116.40% |
36.77% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
0.84% |
|
|
|
|
|
N/A |
0.00% |
54.46% |
15.28% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
0.83% |
|
|
|
|
|
N/A |
0.00% |
42.22% |
5.79% |
|---|
| SWTX |
SPRINGWORKS THERAPEUTICS INC |
|
0.82% |
|
|
|
|
|
|
|
|
|
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
0 |
0.80% |
|
|
|
|
|
N/A |
0.00% |
2,161.69% |
25.33% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
0 |
0.78% |
|
|
|
|
|
N/A |
0.00% |
78.39% |
30.79% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
0 |
0.77% |
|
|
|
|
|
N/A |
0.00% |
76.53% |
11.07% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.77% |
|
|
|
|
|
N/A |
0.00% |
34.98% |
22.10% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
0 |
0.77% |
|
|
|
|
|
N/A |
0.00% |
39.94% |
7.64% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.73% |
|
|
|
|
|
N/A |
0.00% |
48.05% |
19.36% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
0.70% |
|
|
|
|
|
N/A |
0.00% |
38.50% |
2.05% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
0 |
0.67% |
|
|
|
|
|
N/A |
0.00% |
N/A |
33.48% |
|---|
| IMVT |
Immunovant, Inc. |
0 |
0.66% |
|
|
|
|
|
N/A |
0.00% |
38.20% |
35.34% |
|---|
| JANX |
Janux Therapeutics, Inc. |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
75.99% |
23.42% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
78.07% |
67.52% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.62% |
|
|
|
|
|
N/A |
0.00% |
N/A |
31.14% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
0.61% |
|
|
|
|
|
N/A |
0.00% |
98.46% |
32.27% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
68.41% |
57.77% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
71.01% |
29.03% |
|---|
| NUVL |
Nuvalent, Inc. |
0 |
0.58% |
|
|
|
|
|
N/A |
0.00% |
37.54% |
35.80% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.58% |
|
|
|
|
|
N/A |
0.00% |
36.66% |
13.02% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
58.08% |
6.77% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
0 |
0.56% |
|
|
|
|
|
N/A |
0.00% |
45.86% |
18.77% |
|---|
| NVAX |
Novavax, Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
74.53% |
25.28% |
|---|
| VERA |
Vera Therapeutics, Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
62.22% |
14.43% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
81.04% |
36.53% |
|---|
| DVAX |
Dynavax Technologies Corporation |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
31.04% |
26.95% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
317.72% |
12.18% |
|---|
| ARDX |
Ardelyx, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
53.69% |
27.70% |
|---|
| VCEL |
Vericel Corporation |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
60.26% |
70.59% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
58.31% |
13.52% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
647.31% |
36.96% |
|---|
| DNLI |
Denali Therapeutics Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
60.97% |
13.88% |
|---|
| SLNO |
Soleno Therapeutics, Inc. |
0 |
0.42% |
|
|
|
|
|
N/A |
0.00% |
46.52% |
16.85% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
40.62% |
17.91% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
49.01% |
9.63% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
76.45% |
3.68% |
|---|
| PRAX |
Praxis Precision Medicines, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
77.24% |
16.01% |
|---|
| IRON |
Disc Medicine, Inc. |
0 |
0.38% |
|
|
|
|
|
N/A |
0.00% |
51.66% |
16.30% |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
319.78% |
1.37% |
|---|
| SNDX |
Syndax Pharmaceuticals, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
501.54% |
21.13% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
0 |
0.36% |
|
|
|
|
|
N/A |
0.00% |
N/A |
22.11% |
|---|
| SMMT |
Summit Therapeutics Inc. |
0 |
0.32% |
|
|
|
|
|
N/A |
0.00% |
87.90% |
48.40% |
|---|
| MNKD |
MannKind Corporation |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
201.24% |
63.04% |
|---|
| VRDN |
Viridian Therapeutics, Inc. |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
172.50% |
23.31% |
|---|
| NRIX |
Nurix Therapeutics, Inc. |
0 |
0.30% |
|
|
|
|
|
N/A |
0.00% |
135.24% |
31.30% |
|---|
| DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
N/A |
74.56% |
|---|
| SYRE |
Spyre Therapeutics, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
144.93% |
18.73% |
|---|
| TVTX |
Travere Therapeutics, Inc. |
0 |
0.25% |
|
|
|
|
|
N/A |
0.00% |
49.04% |
2.98% |
|---|
| XNCR |
Xencor, Inc. |
0 |
0.25% |
|
|
|
|
|
N/A |
0.00% |
680.85% |
26.12% |
|---|
| CDNA |
CareDx, Inc |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
N/A |
73.60% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
73.30% |
28.32% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
194.40% |
73.49% |
|---|
| CDMO |
AVID BIOSERVICES INC |
|
0.22% |
|
|
|
|
|
|
|
|
|
|---|
| ALT |
Altimmune, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
75.26% |
16.80% |
|---|
| IBRX |
ImmunityBio, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
97.95% |
53.46% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
392.01% |
38.21% |
|---|
| IRWD |
Ironwood Pharmaceuticals, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
199.52% |
10.93% |
|---|
| CGEM |
Cullinan Oncology, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
230.25% |
60.06% |
|---|
| VIR |
Vir Biotechnology, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
210.59% |
68.39% |
|---|
| AVXL |
Anavex Life Sciences Corp. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
104.57% |
52.86% |
|---|
| EBS |
Emergent BioSolutions Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
63.36% |
5.14% |
|---|
| REPL |
Replimune Group, Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
96.21% |
32.42% |
|---|
| VERV |
VERVE THERAPEUTICS INC |
|
0.18% |
|
|
|
|
|
|
|
|
|
|---|